Propylthiouracil

Propylthiouracil

SCHEMBL13723721

CCCc1cc(=O)[nH]c(=S)[nH]1.Cc1cc(=O)[nH]c(=S)[nH]1

nearest known ligand 0.83

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

DIO1TPO

The experimentally established mechanism targets of Propylthiouracil. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TPO known ✓ P07202 1/20 0.83
LPO P22079 2/20 0.83
MPO P05164 1/20 0.83
TSHR P16473 1/20 0.83
CYP2C19 P33261 1/20 0.83
TAS2R38 P59533 1/20 0.83
SMN1; SMN2 Q16637 3/20 0.67
PTGS1 P23219 1/20 0.67
KMT2A Q03164 1/20 0.66
MAPT P10636 1/20 0.51
ALDH1A1 P00352 2/20 0.43
GPR84 Q9NQS5 9/20 0.42
CYB5R3 P00387 2/20 0.42
CYP3A4 P08684 1/20 0.42
LMNA P02545 1/20 0.41
GAA P10253 1/20 0.41
CA1 P00915 1/20 0.41
BAZ2B Q9UIF8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propylthiouracil SCHEMBL5493716 0.91 LPO (1.00) LPOMPOTPOTSHRCYP2C19
Propylthiouracil SCHEMBL41239 0.91 LPO (1.00) LPOMPOTPOTSHRCYP2C19
Propylthiouracil SCHEMBL27995248 0.90 LPO (0.96) LPOMPOTPOTSHRCYP2C19
Methylthiouracil SCHEMBL159989 0.82
SCHEMBL8407853 0.81 KMT2A (0.90) LPOMPOTPOTSHRCYP2C19
Methylthiouracil SCHEMBL5798462 0.80 SMN1; SMN2 (0.95) LPOMPOTPOTSHRCYP2C19
Propylthiouracil SCHEMBL2322792 0.80 CYP2C19 (0.76) LPOMPOTPOTSHRCYP2C19
SCHEMBL10489579 0.79 KMT2A (1.00) LPOMPOTPOTSHRCYP2C19
Propylthiouracil SCHEMBL20771755 0.78 LPO (0.73) LPOMPOTPOTSHRCYP2C19
SCHEMBL11739128 0.78 KMT2A (0.97) LPOMPOTPOTSHRCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103717597-B Heterocyclic compounds as kinase inhibitors 原真股份有限公司 2017-07-04 CN disclosed
CN-103492389-B Pyrazolo [4,3-d] pyrimidine as inhibitors of kinases 原真股份有限公司 2016-09-14 CN disclosed
EP-2699579-A1 PYRAZOLO [4, 3-D]PYRIMIDINES USEFUL AS KINASE INHIBITORS Origenis GmbH (DE) 2014-02-26 EP disclosed
EP-2699572-A1 HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS Origenis GmbH (DE) 2014-02-26 EP disclosed
WO-2012143144-A1 PYRAZOLO [4, 3-D] PYRIMIDINES USEFUL AS KINASE INHIBITORS ORIGENIS GMBH (DE) 2012-10-26 WO disclosed
WO-2012143143-A1 HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS ORIGENIS GMBH (DE) 2012-10-26 WO disclosed